Cochrane Abstracts
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies. Accessed 24 September 2023.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies. Accessed September 24, 2023.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies
First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies [Internet]. In: Cochrane Abstracts. [cited 2023 September 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
ID - 431910
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies
DB - Evidence Central
DP - Unbound Medicine
ER -
